(Q53574639)

15 May 2018

title

Cost-effectiveness of positron emission tomography in breast cancer. (English)

1 reference

15 May 2018

positron emission tomography

main subject

1 reference

J Scott Sloka

1

1 reference

15 May 2018

Peter D Hollett

series ordinal

2

1 reference

15 May 2018

Maria Mathews

series ordinal

3

1 reference

15 May 2018

publication date

1 September 2005

1 reference

15 May 2018

Molecular Imaging and Biology

published in

1 reference

15 May 2018

volume

7

1 reference

15 May 2018

issue

5

1 reference

15 May 2018

page(s)

351-360

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s11307-005-0012-5

exact match

0 references

cites work

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-005-0012-5

Bias in location and selection of studies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11307-005-0012-5

Isolated regional lymph node dissection: morbidity, mortality and economic considerations

21 January 2018

1 reference

12 December 2020

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

1 reference

12 December 2020

Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer

1 reference

12 December 2020

Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update)

1 reference

12 December 2020

Decision analysis in nuclear medicine

1 reference

12 December 2020

[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer

1 reference

12 December 2020

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

12 December 2020

MD@: a physician-friendly decision analysis tool

1 reference

12 December 2020

Health-adjusted life expectancy

1 reference

12 December 2020

Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma

1 reference

12 December 2020

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Deaths among female patients with carcinoma of the breast treated by a surgical procedure only

1 reference

12 December 2020

Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns

1 reference

12 December 2020

Psychosocial benefits of postmastectomy lymphedema therapy

1 reference

12 December 2020

Prognostic analysis of survival in small breast cancers

1 reference

12 December 2020

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

12 December 2020

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

12 December 2020

Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia

1 reference

12 December 2020

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Indications for breast-preserving surgery and adjuvant therapy in early breast cancer.

1 reference

12 December 2020

Physical and psychological morbidity after axillary lymph node dissection for breast cancer.

1 reference

12 December 2020

Quality of life of breast cancer patients with lymphedema.

1 reference

12 December 2020

Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Axillary lymph nodes and breast cancer: a review

1 reference

12 December 2020

Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada.

1 reference

12 December 2020

Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings

1 reference

12 December 2020

Positron emission tomography in breast cancer: a clinicopathological correlation of results

1 reference

12 December 2020

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

1 reference

12 December 2020

Women's experiences of lymphedema

1 reference

12 December 2020

How to perform a comprehensive search for FDG-PET literature.

1 reference

12 December 2020

Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry

1 reference

12 December 2020

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

1 reference

12 December 2020

PET and [18F]-FDG in oncology: a clinical update

1 reference

12 December 2020

Complications of level I and II axillary dissection in the treatment of carcinoma of the breast

1 reference

12 December 2020

Nuclear medicine approaches for detection of axillary lymph node metastases

1 reference

12 December 2020

The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast

1 reference

12 December 2020

Diagnostic value of positron emission tomography for detecting breast cancer

1 reference

12 December 2020

Biologic considerations regarding the one and two step procedures in the management of patients with invasive carcinoma of the breast.

1 reference

12 December 2020

Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy.

1 reference

12 December 2020

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

1 reference

12 December 2020

Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review

1 reference

12 December 2020

Axillary dissection. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists

1 reference

12 December 2020

PET in oncology: will it replace the other modalities?

1 reference

12 December 2020

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

1 reference

12 December 2020

An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography

1 reference

12 December 2020

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group

1 reference

12 December 2020

Comparison of radical mastectomy with alternative treatments for primary breast cancer:A first report of results from a prospective randomized clinical trial

1 reference

12 December 2020

A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma

1 reference

12 December 2020

10.1007/S11307-005-0012-5

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018